- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 09-07-2026: Press Release
09-07-2026 | 08:45 am
09-07-2026 | 08:45 am
Biocon announced pivotal clinical data publications reinforcing its Yesafili™ (Eylea® biosimilar) effectiveness and equivalence. This milestone strengthens its upcoming U.S. launch, expanding patient access and positioning the company for significant market penetration.
No comments yet. Be the first to comment!